Literature DB >> 23415096

Application of receptor theory to allosteric modulation of receptors.

David A Hall1.   

Abstract

In this chapter, three topics are considered. The allosteric two-state model (ATSM) is compared with explicit multiconformational models. This demonstrates that the ATSM encapsulates the common behaviors of any model with at least two active and two inactive conformations: the "states" of the model represent ensembles of active and inactive conformations. A matrix representation of multiconformational models is introduced to provide a compact notation for models with arbitrarily large numbers of conformations. Allosteric modulation is further explored in the context of an operational model of receptor activity which includes constitutive receptor activity. Fitting this model allows the apparent affinity, intrinsic efficacy, and cooperativity constants of a pair of allosteric ligands to be determined. It is also demonstrated that, within certain limits, it is possible to estimate the parameters of the ATSM. Finally, a novel operational model is developed that may allow the analysis of protean ligands. This model requires a nonlinear stimulus function and two parameters to define the efficacy of a ligand. Expressions describing competitive and allosteric interactions under this model are developed and the results of applying null analyses to the data are determined.
Copyright © 2013 Elsevier Inc. All rights reserved.

Mesh:

Substances:

Year:  2013        PMID: 23415096     DOI: 10.1016/B978-0-12-394587-7.00006-3

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  8 in total

1.  'Partial' competition of heterobivalent ligand binding may be mistaken for allosteric interactions: a comparison of different target interaction models.

Authors:  Georges Vauquelin; David Hall; Steven J Charlton
Journal:  Br J Pharmacol       Date:  2015-03-17       Impact factor: 8.739

2.  Kinetic and system bias as drivers of metabotropic glutamate receptor 5 allosteric modulator pharmacology.

Authors:  Kathy Sengmany; Shane D Hellyer; Sabine Albold; Taide Wang; P Jeffrey Conn; Lauren T May; Arthur Christopoulos; Katie Leach; Karen J Gregory
Journal:  Neuropharmacology       Date:  2019-02-11       Impact factor: 5.250

Review 3.  Mechanistic analysis of the function of agonists and allosteric modulators: reconciling two-state and operational models.

Authors:  David Roche; Debora Gil; Jesús Giraldo
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

4.  A method for the quantification of biased signalling at constitutively active receptors.

Authors:  David A Hall; Jesús Giraldo
Journal:  Br J Pharmacol       Date:  2018-04-25       Impact factor: 8.739

5.  Estimation of ligand affinity constants for receptor states in functional studies involving the allosteric modulation of G protein-coupled receptors: implications for ligand bias.

Authors:  Frederick J Ehlert; Michael T Griffin
Journal:  J Pharmacol Toxicol Methods       Date:  2014-01-13       Impact factor: 1.950

6.  Antagonism of human CC-chemokine receptor 4 can be achieved through three distinct binding sites on the receptor.

Authors:  Robert J Slack; Linda J Russell; Nick P Barton; Cathryn Weston; Giovanna Nalesso; Sally-Anne Thompson; Morven Allen; Yu Hua Chen; Ashley Barnes; Simon T Hodgson; David A Hall
Journal:  Pharmacol Res Perspect       Date:  2013-12-30

7.  Quantitative Measure of Receptor Agonist and Modulator Equi-Response and Equi-Occupancy Selectivity.

Authors:  Rumin Zhang; Michael Kavana
Journal:  Sci Rep       Date:  2016-04-27       Impact factor: 4.379

8.  Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists.

Authors:  Laura Ajram; Malcolm Begg; Robert Slack; Jenni Cryan; David Hall; Simon Hodgson; Alison Ford; Ashley Barnes; Dawid Swieboda; Aurelie Mousnier; Roberto Solari
Journal:  Eur J Pharmacol       Date:  2014-02-15       Impact factor: 4.432

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.